LK-Leucocin A (9-14)-KL

General Information


DRACP ID  DRACP04538

Peptide Name   LK-Leucocin A (9-14)-KL

Sequence  LKCTKSGCKL

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C45H85N13O13S2

Absent amino acids  ADEFHIMNPQRVWY

Common amino acids  K

Mass  124109

Pl  9.67

Basic residues  3

Acidic residues  0

Hydrophobic residues  2

Net charge  3

Boman Index  -928

Hydrophobicity  -10

Aliphatic Index  78

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  13.89

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36137364

Title  Designed symmetrical 尾-hairpin peptides for treating multidrug-resistant salmonella typhimurium infections

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20493

DRACP is developed by Dr.Zheng's team.